|
|
|
|
| A ballooning clinical-stage ADC development community is putting stress on both manufacturing capacity and antibody engineering and conjugation talent. What does this burgeon mean for ADC manufacturing, process development, and, ultimately, clinical progress? Join Bioprocess Online Live on July 9th as we navigate the complexity of the ADC manufacturing environment. From linkers to payloads to conjugation, we’ll cover the lay of the land for developers. Registration is free thanks to the support of Cytiva. |
|
|
FOCUS ON ANALYTICS & QUALITY |
|
|
|
By Bioprocess Online Live | In this Bioprocess Online Live event segment we hear audience questions on the cost of next-generation sequencing, the potential of mechanistic modeling, reducing variability between process development and ATMP manufacturing, and what’s still missing from the ATMP manufacturing technology landscape. |
|
|
|
|
ANALYTICS & QUALITY SOLUTIONS |
|
|
|
|
|
|
Business Of Biotech Podcast | Allan Shaw explains how and why the biotech industry should take action to build trust with consumers and Wall Street. |
|
|
|
| Annex 1 Compliance Guidelines For Biological Indicator Users | Article | By Crystal Hostler, Mesa Laboratories | Gain a deeper understanding of the requirements, guidelines, and best practices for Annex 1 compliance whether you're in pharmaceuticals, healthcare, or any field utilizing biological indicators. |
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
